Investigating the health impacts of road pricing in Washington, D.C.
REACH Center Research Project 1
This study is looking at how charging fees for driving in certain areas can help reduce air pollution and improve health, especially for people in Washington, D.C. who suffer from asthma and are most affected by dirty air, and it will also involve talking to community members to make sure their experiences are heard.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-10982793 on NIH RePORTER |
What this research studies
This research focuses on how road pricing, a strategy to reduce vehicle emissions and improve air quality, affects health and equity in Washington, D.C. It aims to understand the relationship between on-road vehicle emissions and asthma cases, particularly in communities disproportionately affected by air pollution. By analyzing data on health outcomes and environmental factors, the study seeks to identify both the benefits and potential unintended consequences of implementing road pricing policies. The research will involve community engagement to ensure that the voices of affected populations are included in the findings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in areas of Washington, D.C. that are heavily impacted by air pollution and related health issues, particularly asthma.
Not a fit: Patients who do not reside in Washington, D.C. or those who do not have health conditions related to air pollution may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved air quality and health outcomes for communities suffering from high levels of air pollution.
How similar studies have performed: Similar studies in other urban areas have shown that road pricing can lead to improved air quality and health outcomes, indicating a potential for success in this approach.
Where this research is happening
Washington, United States
- George Washington University — Washington, United States (Active)
Researchers
- Principal investigator: Henneman, Lucas Richard Fath — George Washington University
- Study coordinator: Henneman, Lucas Richard Fath
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.